GSK's Emma Walmsley awarded £8.4M pay package after £2.5M rise, finally catching up with fellow pharma CEOs
When Emma Walmsley was first appointed as GlaxoSmithKline’s first woman CEO in 2017, the 25% discrepancy between her salary and that of her predecessor, Andrew Witty, drew a few headlines. After three years at the helm, her salary remains pretty much the same at £1.1 million — but a handsome £5.1 million in performance bonuses has helped trigger a £2.5 million pay rise over the last year.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 142,600+ biopharma pros reading Endpoints daily — and it's free.